decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

Weekly NIH Funding Opportunities and Notices
November 2, 2018

General Notices

Funding Opportunities

  • Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)
    (PA-19-042)
    National Institute of Allergy and Infectious Diseases
    National Institute on Drug Abuse
    National Institute of Mental Health
    Application Receipt Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. The first application due date for this FOA is January 7, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed)
    (PA-19-043)
    National Human Genome Research Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional)
    (PA-19-046)
    National Institute on Deafness and Other Communication Disorders
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is ?February 16, 2019.
  • Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional)
    (PA-19-047)
    National Institute on Deafness and Other Communication Disorders
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 5, 2019.
  • New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed)
    (PA-19-049)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 16, 2019.
  • Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)
    (PA-19-050)
    National Institute of Allergy and Infectious Diseases
    National Institute of Mental Health
    Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. The first application due date for this FOA is January 7, 2019.
  • Limited Competition: Extramural Research Facilities Restoration Program: Hurricanes Harvey, Irma, and Maria Disaster Relief (C06 Clinical Trial Not Allowed)
    (PAR-19-041)
    Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
    Application Receipt Date(s): January 4, 2019, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional)
    (PAR-19-044)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 16, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)
    (PAR-19-045)
    National Institute of Nursing Research
    Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 5, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
    (PAR-19-048)
    National Heart, Lung, and Blood Institute
    Application Receipt Date(s): October 18, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this Funding Opportunity Announcement are due on this date.
  • Emerging Global Leader Award (K43 Independent Clinical Trial Required)
    (PAR-19-051)
    John E. Fogarty International Center
    National Cancer Institute
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Human Genome Research Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Office of Research on Women's Health
    Application Receipt Date(s): December 4, 2018; November 7, 2019; and November 4, 2020 by 5:00 PM local time of the applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Centers on the Demography and Economics of Aging (P30 Clinical Trial Optional)
    (RFA-AG-20-001)
    National Institute on Aging
    Application Receipt Date(s): June 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Centers on the Demography and Economics of Alzheimer's Disease and Alzheimer's Related Dementias (P30 Clinical Trial Optional)
    (RFA-AG-20-002)
    National Institute on Aging
    Application Receipt Date(s): June 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Demography and Economics of Aging and AD-ADRD Coordinating Center (R24 Clinical Trial Not Allowed)
    (RFA-AG-20-003)
    National Institute on Aging
    Application Receipt Date(s): June 3, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
    (RFA-AG-20-004)
    National Institute on Aging
    Application Receipt Date(s): April 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)
    (RFA-AT-19-001)
    National Center for Complementary and Integrative Health
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    National Institute on Deafness and Other Communication Disorders
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): February 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3)
    (RFA-CA-19-012)
    National Cancer Institute
    Application Receipt Date(s): February 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)
    (RFA-CA-19-013)
    National Cancer Institute
    National Institute on Aging
    National Institute of Biomedical Imaging and Bioengineering
    Application Receipt Date(s): February 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)
    (RFA-CA-19-014)
    National Cancer Institute
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)
    (RFA-CA-19-015)
    National Cancer Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): February 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required)
    (RFA-CA-19-018)
    National Cancer Institute
    Application Receipt Date(s): February 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)
    (RFA-DK-18-014)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): February 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
    (RFA-MH-19-235)
    National Institute of Mental Health
    Application Receipt Date(s): February 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional)
    (RFA-NS-19-008)
    National Institute of Neurological Disorders and Stroke
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Eye Institute
    National Institute of Mental Health
    National Institute of Nursing Research
    National Center for Complementary and Integrative Health
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): February 28, 2019 No late applications will be accepted for this Funding Opportunity Announcement.
  • Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional)
    (RFA-NS-19-009)
    National Institute of Neurological Disorders and Stroke
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Eye Institute
    National Institute of Mental Health
    National Institute of Nursing Research
    National Center for Complementary and Integrative Health
    National Institute of Biomedical Imaging and Bioengineering
    Office of Behavioral and Social Sciences Research
    Application Receipt Date(s): February 28, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
    (RFA-NS-19-013)
    National Institute of Neurological Disorders and Stroke
    National Institute on Aging
    Application Receipt Date(s): January 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition: Restoring Research Resources Lost or Damaged Due to Hurricanes Harvey, Irma, and Maria (R24 Clinical Trial Optional)
    (RFA-OD-18-102)
    National Institutes of Health
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute of General Medical Sciences
    National Cancer Institute
    National Institute on Drug Abuse
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Eye Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Human Genome Research Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Complementary and Integrative Health
    National Institute of Biomedical Imaging and Bioengineering
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): December 14, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.